pasireotide and Vomiting

pasireotide has been researched along with Vomiting* in 1 studies

Trials

1 trial(s) available for pasireotide and Vomiting

ArticleYear
New insights on SOM230, a universal somatostatin receptor ligand.
    Journal of endocrinological investigation, 2003, Volume: 26, Issue:8 Suppl

    Topics: Acromegaly; Dose-Response Relationship, Drug; Drug Evaluation; Drug Tolerance; Drugs, Investigational; Human Growth Hormone; Nausea; Octreotide; Receptors, Somatostatin; Reference Values; Somatostatin; Vomiting

2003